CSIRO Publishing blank image blank image blank image blank imageBooksblank image blank image blank image blank imageJournalsblank image blank image blank image blank imageAbout Usblank image blank image blank image blank imageShopping Cartblank image blank image blank image You are here: Journals > Sexual Health   
Sexual Health
Journal Banner
  Publishing on sexual health from the widest perspective
 
blank image Search
 
blank image blank image
blank image
 
  Advanced Search
   

Journal Home
About the Journal
Editorial Structure
Contacts
Content
Online Early
Current Issue
Just Accepted
All Issues
Special Issues
Sample Issue
For Authors
General Information
Scope
Submit Article
Author Instructions
Open Access
For Referees
Referee Guidelines
Review an Article
Annual Referee Index
For Advertisers
For Subscribers
Subscription Prices
Customer Service

blue arrow e-Alerts
blank image
Subscribe to our Email Alert or RSS feeds for the latest journal papers.

red arrow Connect with us
blank image
facebook twitter LinkedIn

red arrow Interview with Kit Fairley
blank image
Hear Kit Fairley speak about what is sexual health.

 

Article << Previous     |     Next >>   Contents Vol 11(2)

Bringing new HIV infections to zero – opportunities and challenges offered by antiretroviral-based prevention in Asia, the Pacific and beyond: An overview of this special issue

Iryna B. Zablotska A M, Bill Whittaker B C, John de Wit D, Adeeba Kamarulzaman E, Jintanat Ananworanich F K L, Edwina Wright G, Isobel Mary Poynten A and Kenneth Mayer H I J

A Kirby Institute for Infection and Immunity in Society, University of New South Wales, Sydney, NSW, Australia.
B National Association of People with HIV (NAPWA), Sydney, NSW 2042, Australia.
C Pacific Friends of the Global Fund to Fight AIDS, TB and Malaria, Sydney, NSW 2010, Australia.
D Centre for Social Research in Health, University of New South Wales, Sydney, NSW 2052, Australia.
E Centre of Excellence for Research in AIDS, University of Malaya, Kuala Lumpur 59990, Malaysia.
F The Thai Red Cross AIDS Research Center, Bangkok 10330, Thailand.
G The Alfred Hospital and Burnet Institute, Melbourne, Vic. 3004, Australia.
H Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.
I Harvard Medical School and School of Public Health, Boston, MA 02115, USA.
J The Fenway Institute, Fenway Health, Boston, MA02115, USA.
K US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA.
L Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD 20817, USA.
M Corresponding author. Email: izablotska@kirby.unsw.edu.au

Sexual Health 11(2) 97-100 http://dx.doi.org/10.1071/SH14071
Submitted: 8 April 2014  Accepted: 9 April 2014   Published: 14 July 2014


 
 Full Text
 PDF (161 KB)
 Export Citation
 Print
  
Abstract

This editorial to the special issue of Sexual Health on antiretroviral-based prevention of HIV infection is dedicated to showcasing research and practice in this area. It aims to promote debate regarding the potential of new antiretroviral-based prevention approaches and the challenges encountered in moving prevention innovations into the community. This special issue covers the breadth of innovative HIV prevention research, including that undertaken in the fields of epidemiology, clinical research, social and behavioural science, public health and policy analysis, and with special emphasis on Asia and the Pacific region. Most importantly, it provides an indication of how the region is progressing towards embracing new prevention approaches to combat HIV epidemics across the region.



References

[1]  Grant RM, Wainberg MA. Chemoprophylaxis of HIV infection: moving forward with caution. J Infect Dis 2006; 194: 874–6.
CrossRef | CAS | PubMed |

[2]  Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, et al Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2013; 381: 2083–90.
CrossRef | PubMed |

[3]  Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 2012; 367: 399–410.
CrossRef | CAS | PubMed |

[4]  Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365: 493–505.
CrossRef | CAS | PubMed |

[5]  Padian NS, McCoy SI, Karim SS, Hasen N, Kim J, Bartos M, et al HIV prevention transformed: the new prevention research agenda. Lancet 2011; 378: 269–78.
CrossRef | PubMed |

[6]  The Joint United Nations Programme on HIV/AIDS (UNAIDS). Global fact sheet. Geneva: UNAIDS; 2012. Available online at: http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/20121120_factsheet_global_en.pdf [verified May 2014].

[7]  Whittaker B. Transforming Australia’s HIV prevention and treatment efforts to achieve an AIDS-free generation: the United Nations Political Declaration on HIV/AIDS and the Melbourne Declaration ‘Action on HIV’. Sex Health 2014; 11: 101–6.
CrossRef |

[8]  Cassell MM, Holtz TH, Wolfe MI, Hahn M, Prybylski DP. ‘Getting to zero’ in Asia and the Pacific through more strategic use of antiretrovirals for HIV prevention. Sex Health 2014; 11: 107–18.
CrossRef |

[9]  Phuphuakrat A, Kiertiburanakul S, Sungkanuparph S. Current status of HIV treatment in Asia and the Pacific region. Sex Health 2014; 11: 119–25.
CrossRef |

[10]  Lo YR, Kato M, Phanupak N, Fujita M, Duc DB, Sopheap S, et al Challenges and potential barriers to the uptake of ARV-based prevention in Asia and the Pacific region. Sex Health 2014; 11: 126–36.
CrossRef |

[11]  de Wit JBF, Adam PCG. Can treatment-based HIV prevention curb the epidemic among gay and other men who have sex with men? A narrative synthesis of increasing evidence for moderating and countervailing effects. Sex Health 2014; 11: 137–45.
CrossRef |

[12]  Jansson J, Kerr CC, Wilson DP. Predicting the population impact of increased HIV testing and treatment in Australia. Sex Health 2014; 11: 146–54.
CrossRef |

[13]  Anderson PL, Glidden DV, Liu A, Buchbinder S, Lama JR, Guanira JV, et al Emtricitabine–tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Science Translational Medicine 2012; 4: 151ra125
CrossRef | PubMed |

[14]  US Centers for Disease Control and Prevention. Update to interim guidance for pre-exposure prophylaxis (PrEP) for the prevention of HIV infection: PrEP for injecting drug users. MMWR Morb Mortal Wkly Rep 2013; 62: 463–5.
| PubMed |

[15]  Amico KR. The key role of adherence for the effectiveness of antiretroviral-based prevention: state of the science and implications for Asia-Pacific region. Sex Health 2014; 11: 155–65.
CrossRef |

[16]  Holt M. HIV pre-exposure prophylaxis and treatment as prevention: a review of awareness and acceptability among men who have sex with men in the Asia-Pacific region and the Americas. Sex Health 2014; 11: 166–70.
CrossRef |

[17]  Down I, Prestage G, Triffitt K, Brown G,, Bradley J, Ellard J. Recently diagnosed gay men talk about HIV treatment decisions. Sex Health 2014; 11: 200–6.
CrossRef |

[18]  Chandhiok N, Joshi SN, Gangakhedkar R. Acceptability of oral and topical HIV chemoprophylaxis in India: implications for at-risk women and men who have sex with men. Sexual Health 2014; 11: 171–9.
CrossRef |

[19]  van Griensven F, Phanuphak N, Srithanaviboonchai K. Biomedical HIV prevention research and epidemic control in Thailand: two sides of the same coin. Sex Health 2014; 11: 180–99.
CrossRef |

[20]  Dallabetta G, Chandrasekaran P, Wheeler T, Das A, Ramakrishanan L, Kumta S, et al Rolling out new biomedical HIV prevention tools: what can be learned from Avahan, the India AIDS Initiative? Sex Health 2014; 11: 207–16.
CrossRef |

[21]  The Joint United Nations Programme on HIV/AIDS (UNAIDS). Regional fact sheet 2012: Asia and the Pacific. Geneva: UNAIDS Communications; 2012. Available online at: http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/2012_FS_regional_asia_pacific_en.pdf [verified May 2014].

[22]  The Joint United Nations Programme on HIV/AIDS (UNAIDS). Sex work and the law in Asia and the Pacific. Report. Geneva: UNAIDS; 2013. Available online at: http://www.undp.org/content/undp/en/home/presscenter/pressreleases/2012/10/18/new-un-report-takes-a-stark-look-at-links-between-sex-work-hiv-and-the-law-in-asia-and-the-pacific/ [verified 19 May 2014].

[23]  Global Commission on Drug Policy. The war on drugs and HIV/AIDS: how the criminalization of drug use fuels the global pandemic. Rio de Janeiro: Global Commission on Drug Policy; 2012. Available online at: http://www.globalcommissionondrugs.org/reports/ [verified 19 May 2014].

[24]  Reid G, Devaney ML, Baldwin S. Harm reduction programmes in the Asia–Pacific region. Drug Alcohol Rev 2008; 27: 95–8.
CrossRef | PubMed |

[25]  The Joint United Nations Programme on HIV/AIDS (UNAIDS). Country ownership for a sustainable AIDS response: from principles to practice. Discussion paper. Geneva: UNAIDS; 2012. Available online at: http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2012/20120717_JC2134_UNAIDS_Country_Ownership_Discussion_Paper.pdf [verified May 2014].


   
 
    
Legal & Privacy | Contact Us | Help

CSIRO

© CSIRO 1996-2015